PHPMem v2.0.1

Version
1.6.45
Uptime
15 days 18 hours 10 minutes 22 seconds

Memory

Total
512MB
Used
9,38MB (1.83%)
Free
502,62MB

Keys

Current
11 436
Total (since start)
35 066
Evictions
0
Reclaimed
738
Expired Unfetched
0
Evicted Unfetched
0

Connections

Current
8 / 1 024 max
Total
177 914
Rejected
0
llm:91971e3cedee85e40d4da7a1bca7b9e38f6836bd1e0cb3a1f173f96eecabea4f
TTL 10 hours 26 minutes 11 seconds Size 2,27KB Export
Edit
### 1.1 Business Data Landscape This dataset represents a **clinical trial adverse event tracking system**, comprising two core entities that capture patient safety and study participation data. The **ae** table (1,191 rows) functions as the path table, logging individual adverse event records throughout the trial lifecycle, while the **adsl** table (306 rows) serves as the dimension table, maintaining subject-level demographic and study assignment information. The 4:1 ratio of adverse events to subjects suggests an average of approximately four safety observations per enrolled participant. This structure is characteristic of pharmaceutical or medical device trials where regulatory compliance demands granular documentation of every safety signal. The dataset's compact 1.0 MB footprint indicates this is either a single-site study or an early-phase trial with limited enrollment. ### 1.2 Key Data Assets | Table | Role | Rows | % of Total | Size | |-------|------|-----:|----------:|-----:| | ae | path | 1,191 | 79.6% | 0.7 MB | | adsl | dimension | 306 | 20.4% | 0.3 MB | The **ae** table dominates the dataset at 80% of total rows, reflecting the operational reality that adverse event documentation generates the bulk of safety data volume in clinical research. The **adsl** table provides the foundational subject roster against which all safety events should be analyzed, representing the 306 individuals enrolled in this study. ### 1.3 Data Integration Posture Despite the clear semantic relationship between subjects and their adverse events, **no technical joins were detected** between these two tables, leaving them operationally siloed. This absence of validated foreign key relationships means cross-functional safety analysis—such as calculating adverse event rates by demographic subgroup or treatment arm—currently requires manual linkage logic that introduces risk of mismatched records. For a clinical dataset where regulatory submissions demand auditable traceability from each adverse event back to its source subject, this disconnected posture represents a significant gap in data infrastructure that limits both analytical efficiency and compliance confidence.